Dariusz Wołowiec

1.8k total citations
81 papers, 1.4k citations indexed

About

Dariusz Wołowiec is a scholar working on Genetics, Pathology and Forensic Medicine and Immunology. According to data from OpenAlex, Dariusz Wołowiec has authored 81 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Genetics, 31 papers in Pathology and Forensic Medicine and 24 papers in Immunology. Recurrent topics in Dariusz Wołowiec's work include Chronic Lymphocytic Leukemia Research (39 papers), Lymphoma Diagnosis and Treatment (25 papers) and Immunodeficiency and Autoimmune Disorders (16 papers). Dariusz Wołowiec is often cited by papers focused on Chronic Lymphocytic Leukemia Research (39 papers), Lymphoma Diagnosis and Treatment (25 papers) and Immunodeficiency and Autoimmune Disorders (16 papers). Dariusz Wołowiec collaborates with scholars based in Poland, France and United States. Dariusz Wołowiec's co-authors include Kazimierz Kuliczkowski, Bruno Quesnel, Valérie Coiteux, Abdelbasset Hamrouni, Aurore Saudemont, Jizhong Liu, Dominique Hétuin, Irena Frydecka, Donata Urbaniak‐Kujda and Tadeusz Robak and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and International Journal of Molecular Sciences.

In The Last Decade

Dariusz Wołowiec

74 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dariusz Wołowiec Poland 20 661 621 401 370 347 81 1.4k
Karoline Sonneck Austria 23 360 0.5× 1.0k 1.6× 519 1.3× 374 1.0× 494 1.4× 40 1.9k
Luc Van Rompaey Belgium 16 594 0.9× 285 0.5× 568 1.4× 411 1.1× 493 1.4× 31 1.4k
Mirosław Majewski Poland 16 456 0.7× 292 0.5× 522 1.3× 279 0.8× 308 0.9× 28 1.4k
Francesca Arruga Italy 20 312 0.5× 332 0.5× 502 1.3× 550 1.5× 394 1.1× 60 1.3k
Evdoxia Hatjiharissi United States 21 649 1.0× 555 0.9× 724 1.8× 726 2.0× 727 2.1× 86 2.0k
Cristina Rabascio Italy 17 556 0.8× 306 0.5× 476 1.2× 209 0.6× 272 0.8× 33 1.1k
Stacey M. Fernandes United States 20 322 0.5× 532 0.9× 581 1.4× 809 2.2× 279 0.8× 81 1.6k
Marc A. Weniger United States 18 605 0.9× 366 0.6× 670 1.7× 349 0.9× 164 0.5× 34 1.6k
Georgios Z. Rassidakis United States 17 414 0.6× 234 0.4× 489 1.2× 207 0.6× 231 0.7× 34 1.0k
Polly Pine United States 15 357 0.5× 1.0k 1.6× 337 0.8× 245 0.7× 167 0.5× 24 1.6k

Countries citing papers authored by Dariusz Wołowiec

Since Specialization
Citations

This map shows the geographic impact of Dariusz Wołowiec's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dariusz Wołowiec with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dariusz Wołowiec more than expected).

Fields of papers citing papers by Dariusz Wołowiec

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dariusz Wołowiec. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dariusz Wołowiec. The network helps show where Dariusz Wołowiec may publish in the future.

Co-authorship network of co-authors of Dariusz Wołowiec

This figure shows the co-authorship network connecting the top 25 collaborators of Dariusz Wołowiec. A scholar is included among the top collaborators of Dariusz Wołowiec based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dariusz Wołowiec. Dariusz Wołowiec is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hus, Iwona, Krzysztof Giannopoulos, Krzysztof Jamroziak, et al.. (2025). Rekomendacje diagnostyczne i terapeutyczne dla przewlekłej białaczki limfocytowej w 2025 roku — Raport Grupy Roboczej PTHiT i PALG-CLL. SHILAP Revista de lepidopterología. 5(1-2). 20–47. 1 indexed citations
2.
Witkowska, Magdalena, Joanna Romejko‐Jarosińska, Agnieszka Giza, et al.. (2025). Primary Renal Lymphoma: Report of 32 Cases—A Retrospective Multicenter PLRG Analysis. Biomedicines. 13(3). 548–548.
3.
4.
Wołowiec, Dariusz, et al.. (2023). Immuno-Stimulating Activity of 1,25-Dihydroxyvitamin D in Blood Cells from Five Healthy People and in Blasts from Five Patients with Leukemias and Pre-Leukemic States. International Journal of Molecular Sciences. 24(7). 6504–6504. 4 indexed citations
5.
Wołowiec, Dariusz, Barbara Wysoczańska, Piotr Łacina, et al.. (2021). NF-κB1 -94del/del ATTG polymorphic variant maintains CLL at an early, mildest stage. Advances in Clinical and Experimental Medicine. 30(5). 499–506.
6.
Jasek, Monika, Agnieszka Bojarska−Junak, Maciej Sobczyński, et al.. (2020). Association of Common Variants of TNFSF13 and TNFRSF13B Genes with CLL Risk and Clinical Picture, as Well as Expression of Their Products—APRIL and TACI Molecules. Cancers. 12(10). 2873–2873. 5 indexed citations
7.
Karabon, Lidia, Anna Partyka, Lidia Ciszak, et al.. (2020). Abnormal Expression of BTLA and CTLA‐4 Immune Checkpoint Molecules in Chronic Lymphocytic Leukemia Patients. Journal of Immunology Research. 2020(1). 6545921–6545921. 27 indexed citations
8.
Wołowiec, Dariusz. (2018). Interpretation of laboratory tests in general practice. 4(1). 8–14.
9.
Jasek, Monika, Agnieszka Bojarska−Junak, Marta Wagner, et al.. (2016). Association of variants in BAFF (rs9514828 and rs1041569) and BAFF-R (rs61756766) genes with the risk of chronic lymphocytic leukemia. Tumor Biology. 37(10). 13617–13626. 12 indexed citations
10.
Urbaniak‐Kujda, Donata, Katarzyna Kapelko‐Słowik, Jarosław Dybko, et al.. (2015). Increased expression of metalloproteinase-2 and -9 (MMP-2, MMP-9), tissue inhibitor of metalloproteinase-1 and -2 (TIMP-1, TIMP-2), and EMMPRIN (CD147) in multiple myeloma. Hematology. 21(1). 26–33. 21 indexed citations
11.
Puła, Bartosz, Dariusz Wołowiec, Janusz Ryś, et al.. (2013). Expression of metallothionein and Ki-67 antigen in GISTs of different grade of malignancy.. PubMed. 22(4). 513–8. 5 indexed citations
12.
Franiak‐Pietryga, Ida, Henryk Maciejewski, Dariusz Wołowiec, et al.. (2012). Changes in the apoptotic gene expression profile in CLL patients treated with rituximab combined with cladribine and cyclophosphamide-preliminary results. Leukemia Research. 36(9). 1134–1140. 1 indexed citations
13.
Karabon, Lidia, Anna Tomkiewicz, Dariusz Wołowiec, et al.. (2011). ICOS gene polymorphisms in B-cell chronic lymphocytic leukemia in the Polish population. SHILAP Revista de lepidopterología. 1 indexed citations
14.
Kapelko‐Słowik, Katarzyna, Donata Urbaniak‐Kujda, Dariusz Wołowiec, et al.. (2010). Human Pim-2 Gene Expression in Acute Myeloid and Acute Lymphoblastic Leukemia Patients and Complete Remission. Advances in Clinical and Experimental Medicine. 19(1). 99–104. 1 indexed citations
15.
Kosmaczewska, Agata, et al.. (2009). Is Cyclin D2 a Marker of B-CLL Cell Activation?. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics. 18(2). 127–131. 3 indexed citations
16.
Kuranda, Klaudia, Céline Berthon, Caroline Dupont, et al.. (2009). A subpopulation of malignant CD34+CD138+B7-H1+ plasma cells is present in multiple myeloma patients. Experimental Hematology. 38(2). 124–131.e4. 26 indexed citations
17.
Kowal, Małgorzata, Anna Dmoszyńska, Krzysztof Lewandowski, et al.. (2004). Efficacy and Safety of Fludarabine and Cyclophosphamide Combined Therapy in Patients with Refractory/Recurrent B-Cell Chronic Lymphocytic Leukaemia (B-CLL)—Polish Multicentre Study. Leukemia & lymphoma. 45(6). 1159–1165. 14 indexed citations
18.
Robak, Tadeusz, Jerzy Z. Błoński, Marek Kasznicki, et al.. (2002). Cladribine combined with cyclophosphamide is highly effective in the treatment of chronic lymphocytic leukemia. The Hematology Journal. 3(5). 244–250. 38 indexed citations
19.
Robak, Tadeusz, Marek Kasznicki, Joanna Góra‐Tybor, et al.. (2002). Re‐treatment with cladribine‐based regimens in relapsed patients with B‐cell chronic lymphocytic leukemia. European Journal Of Haematology. 69(1). 27–36. 10 indexed citations
20.
Wołowiec, Dariusz & Martine Ffrench. (1993). [Cyclins A and B: redundancy and specificity].. PubMed. 41(6). 547–53. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Karoline Sonneck Breakdown of academic impact, for papers by Luc Van Rompaey Breakdown of academic impact, for papers by Mirosław Majewski Breakdown of academic impact, for papers by Francesca Arruga Breakdown of academic impact, for papers by Evdoxia Hatjiharissi Breakdown of academic impact, for papers by Cristina Rabascio Breakdown of academic impact, for papers by Stacey M. Fernandes Breakdown of academic impact, for papers by Marc A. Weniger Breakdown of academic impact, for papers by Georgios Z. Rassidakis Breakdown of academic impact, for papers by Polly Pine
Rankless by CCL
2026